Pharmacy
PBMs’ overseas group purchasing organizations may be used to avoid transparency and oversight, committee says.
“Providers don’t want to see rebate models, period,” says Attorney Jeff Davis.
Mike Motz is replacing Tim Wentworth as CEO of Walgreens.
Monarez "is not aligned with the president’s agenda of Making America Healthy Again," says White House spokesperson.
The merger is intended to lower the cost of specialty medications and high-cost drug classes like GLP-1s.
FDA is requiring labels featuring clearer risk information, warnings on dosing and drug interactions and treatment guidance.
The company says broad tariffs would raise costs, limit patient access and undermine domestic manufacturing.
Managing the cost of GLP-1 drugs for weight loss is the top priority in pharmacy benefits, says Mercer survey.
The groups are requesting an extension of the comment and application periods to give HRSA more time to review requests.
The ruling dismisses a case brought by several chambers of commerce and their drug manufacturer members.